By Femtech Insider Breast Health, News, Pharma, Regulatory May 26, 2026 ShareTwitterFacebookPinterest-circled FDA Approves DATROWAY for Triple-Negative Breast Cancer, Delivering Median Survival of Two Years
By Femtech Insider Breast Health, Cancer, News, Pharma May 19, 2026 ShareTwitterFacebookPinterest-circled FDA Approves ENHERTU for Early Breast Cancer in Two New Indications
By Femtech Insider Breast Health, Cancer, News May 11, 2026 ShareTwitterFacebookPinterest-circled Artera Receives FDA Clearance for AI-Powered Breast Cancer Risk Stratification Tool
By Femtech Insider Breast Health, Cancer, News May 5, 2026 ShareTwitterFacebookPinterest-circled FDA Approves VEPPANU, a New Class of Targeted Therapy for Advanced Breast Cancer
By Femtech Insider Breast Health, Cancer, Investment, News April 20, 2026 ShareTwitterFacebookPinterest-circled ScreenPoint Medical Raises $16M to Scale AI-Powered Breast Cancer Detection Globally
By Femtech Insider Breast Health, Cancer, News, Pharma March 20, 2026 ShareTwitterFacebookPinterest-circled Novartis Acquires Next-Generation Breast Cancer Drug in $3 Billion Deal
By Femtech Insider Breast Health, Cancer, News, Partnership March 17, 2026 ShareTwitterFacebookPinterest-circled Manta Cares and Gilead Sciences Announce Collaboration to Support Patients Navigating Metastatic Breast and Lung Cancer
By Femtech Insider Breast Health, Cancer, Ecosystem, News, Research March 5, 2026 ShareTwitterFacebookPinterest-circled iMerit, Segmed, and Advocate Health Release Open-Source 3D Mammography Dataset for AI Research
